Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
      Description

      This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in subjects with Age-Associated Memory Impairment (AAMI)

      Conditions
      Age-Associated Memory Impairment (AAMI)
      Talk to us
      COMPLETED
      A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)
      Description

      The purpose of this Phase II study is to evaluate the efficacy and safety of ispronicline (TC-1734-112) compared to placebo (inactive substance pill) in patients with age associated memory impairment (AAMI). AAMI is characterized as cognitive impairment including memory loss and poor concentration associated with aging.

      Conditions
      Age-Related Memory Disorders
      Talk to us